Obada Al-Zghool

Preclinical development of radiopharmaceuticals for Alzheimer’s disease: Biological evaluation of (S)-[18F]THK5117 and [11C]SMW139 PET tracers in the APP/PS1-21 mouse model of Alzheimer’s disease (2024)

Al-Zghool Obada

(G5 Artikkeliväitöskirja)

Novel plasma protein binding analysis method for a PET tracer and its radiometabolites: A case study with [11C]SMW139 to explain the high uptake of radiometabolites in mouse brain (2022)

Journal of Pharmaceutical and Biomedical Analysis

Aarnio Richard, Alzghool Obada M, Wahlroos Saara, O'Brien-Brown James, Kassiou Michael, Solin Olof, Rinne Juha O, Forsback Sarita, Haaparanta-Solin Merja

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives (2022)

Movement Disorders

Obada M. Alzghool, van Dongen Goos, van de Giessen Elsemarike, Schoonmade Linda, Beaino Wissam

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

(S)-[18F]THK5117 brain uptake is associated with Aβ plaques and MAO-B enzyme in a mouse model of Alzheimer's disease (2021)

Neuropharmacology

Alzghool Obada M, Rokka Johanna, López-Picón Francisco R, Snellman Anniina, Helin Jatta S, Okamura Nobuyuki, Solin Olof, Rinne Juha O, Haaparanta-Solin Merja

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

[18F]F-DPA for the detection of activated microglia in a mouse model of Alzheimer's disease (2018)

Nuclear Medicine and Biology

Keller T, López-Picón FR, Krzyczmonik A, Forsback S, Kirjavainen AK, Takkinen JT, Alzghool O, Rajander J, Teperi S, Cacheux F, Damont A, Dollé F, Rinne JO, Solin O, Haaparanta-Solin M

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Preclinical development of radiopharmaceuticals for Alzheimer’s disease: Biological evaluation of (S)-[18F]THK5117 and [11C]SMW139 PET tracers in the APP/PS1-21 mouse model of Alzheimer’s disease (2024)

Novel plasma protein binding analysis method for a PET tracer and its radiometabolites: A case study with [11C]SMW139 to explain the high uptake of radiometabolites in mouse brain (2022)

α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives (2022)

(S)-[18F]THK5117 brain uptake is associated with Aβ plaques and MAO-B enzyme in a mouse model of Alzheimer's disease (2021)

[18F]F-DPA for the detection of activated microglia in a mouse model of Alzheimer's disease (2018)